Navigation Links
Hopkins researchers develop new tool to watch real-time chemical activity in cells

Attempts to identify potential drugs that interfere with the action of one particular enzyme linked to heart disease and similar health problems led scientists at Johns Hopkins to create a new tool and new experimental approach that allow them to see multiple, real-time chemical reactions in living cells. Their report on the work is published July 21 in the journal ACS Chemical Biology.

Most current drug development operations test chemicals on enzymes isolated from their normal environs and then take further steps to see if the chemical can get into the cell to do its work, and figure out how poisonous the chemical is to a cell.

"Living cells are critical to our work because they show us how and what is actually happening in a normal context and time span when a chemical is added," says Jin Zhang, Ph.D., an assistant professor of pharmacology and molecular sciences in Hopkins' Institute for Basic Biomedical Sciences.

Testing chemicals on enzymes in living cells provides the opportunity to find potential drugs that work in new ways. For example, using living cells allows researchers to "see" where in the cell chemicals do their work. Scientists could then design new drugs to go to specific places within cells to work more efficiently. Also, streamlining the one-at-a-time approach offers the chance to study - and rule out or in - many potentially useful chemicals at once.

What Zhang's team developed is a biosensor and simple testing procedure that tells if a particular enzyme - called PKA - that acts like a "switch" is "on" or "off" in a living cell. The group has been focused on trying to understand and interfere with this enzyme switch, because if the enzyme is turned on at the wrong time or at the wrong place within cells, it can lead to cells misbehaving, which ultimately can lead to heart disease.

In the course of their work, the team built a protein biosensor that indicates if an enzyme located nearby is turned
'"/>

Source:Johns Hopkins Medical Institutions


Page: 1 2 3

Related biology news :

1. Hopkins AIDS experts issue warning about global efforts to provide drug therapies
2. Hopkins scientists uncover tags that force proteins to cell surface
3. Johns Hopkins flu expert calls for mandatory vaccination of health care workers
4. Whole-genome study at Johns Hopkins reveals a new gene associated with abnormal heart rhythm
5. Hopkins researchers discover genetic switch that turns off an oxygen-poor cells combustion engine
6. Hopkins study suggests commercially available antibiotic may help fight dementia in HIV patients
7. Johns Hopkins lab scientists tame overactive CF protein
8. Hopkins scientists show hallucinogen in mushrooms creates universal mystical experience
9. Hopkins researchers discover how brain protein might control memory
10. Hopkins scientists link immune response to ghost parasites and severely congested sinuses
11. NYU researchers simulate molecular biological clock

Post Your Comments:
(Date:11/24/2009)..., The atomic-level action of a remarkable class o... researchers with the Lawrence Berkeley National L...protein crystallography beamline at the Advanced L...al roles in gene expression and replication, and a...as well as infectious agents, such as the human pa...
(Date:11/24/2009)..., What constitutes fish food is a matter of deba... that fish get almost 50 percent of their carbon f...nk between the terrestrial and aquatic ecosystems....ngton shows this is not likely to be true. Algae p...ic life, according to research published this week...
(Date:11/23/2009)..., Washington, D.C. The community-associated stra... bacteria resistant to most common antibioticspose...n and is making its way into hospitals, according ...ctious Diseases . , The new threat is easily pi...lic places and has increased the overall burden of...
Breaking Biology News(10 mins):Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3New study finds MRSA on the rise in hospital outpatients 2California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 1California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 2Mad As Hell Doctors to Hold Final 26quot 3BWhite Ribbon Rally 26quot 3B for Single Payer in Washington D C on September 30th 58388 1Mad As Hell Doctors to Hold Final 26quot 3BWhite Ribbon Rally 26quot 3B for Single Payer in Washington D C on September 30th 58388 2Mad As Hell Doctors to Hold Final 26quot 3BWhite Ribbon Rally 26quot 3B for Single Payer in Washington D C on September 30th 58388 3Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 1Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 2Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 3Outbursts 3A Where did Their IQ points Go and What were They Thinking 3F 58385 4
...fly? The fly,s secret in avoiding death in this wa...out of the way. "This kind of low-power decision-m...omously navigating robots", according to Gwyneth C... will be presenting her work on triggered escape r...nual Main Meeting in Barcelona, on Wednesday 13th ...
...e creation of reading matter, a "nano-printing" te...duction of nano-devices currently built one at a t...vation is the DNA microarray, a nano-device used t...s Alzheimer,s, viral illnesses such as AIDS, and c...uce these complex devices would make DNA analysis ...
...dard for treating newborns suffering from opiate w...ates themselves are superior to sedatives for trea...adone while pregnant. , Opiates appear to better "...potentially reduce the likelihood of seizures," ac...d Osborn, a neonatologist at the Royal Prince Alfr...
Other Biology News:New technique may speed DNA analysis 2Opiates Better Than Sedatives For Treating Newborns In Withdrawal 2
(Date:11/25/2009)...tochromatodayannouncedtheappointmentofPeterMoldt,P...kSporkastheNovoA/SrepresentativeontheCompany,sBoar...ers. ,, "WeareverypleasedtowelcomePeterMoldttot...andguidanceasCytochromacontinuestomakeprogressinbe...mpany,"statedAlanLewis,PhD,ChairmanofCytochroma,sB...
(Date:11/25/2009)...Call/--ArdeaBiosciences,Inc.(Nasdaq: RDEA )announc...executiveofficer,willpresentatthePiperJaffray21stA...areasfollows:,PiperJaffray21stAnnualHealthCareCon...asternTime,Location:TheNewYorkPalaceHotel,NewYork,...ye/,target=,_blank,title=,http://www.corporate-ir...
(Date:11/24/2009)...also Visit Detroit , (Voc...ench Ambassador for International Investment, and ... , , ,What: Ambassador Appia is available to meet...ives adopted by France to further develop the fina...n and development., , ,When: Available for Intervi...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--DowAgroSciencesCanadaanno...isionofThompsonsLimitedofBlenheim,Ontario.Theaddit...urrentseedsbusinessasthecompanyanticipatestheintro...esHerbicideTolerantTraitTechnologyincornin2012.The... "Thisacquisitionbringstogethertwostrongprogressiv...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...e Growth Plan on Tuesday, May 20th, FREDERICK, Md...), the maker of the ActiPatch(TM), a drug free,ant...ated microchip,delivering weeks of continuous puls... it will hold a conference call to update investor...pany. Andrew Whelan, President and CEO of,BioElect...
...al, Inc., a,developer of innovative therapies in w... $49.5 million in Series D preferred stock financi...reeArch Partners and Skyline,Ventures also partici...articipation by existing investors Affinity Capita... Venture Partners, INVESCO Private Capital,JP Morg...
...n in 2008 -, FREMONT, Calif., May 15 Vermillion,...mpany, today announced financial,results for the f... update,on recent corporate and clinical developme...strated significant clinical,and commercialization...e,programs target significant unmet clinical needs...
Other Biology Technology:BioElectronics Announces Conference Call to Update Investors on Growth Initiatives 2BioElectronics Announces Conference Call to Update Investors on Growth Initiatives 3Novasys Medical Secures $49.5 Million in Series D Financing to Expand Commercialization of Its Renessa(R) Treatment for Incontinence in Women 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 2Vermillion Announces First Quarter 2008 Financial Results and Business Progress 3Vermillion Announces First Quarter 2008 Financial Results and Business Progress 4Vermillion Announces First Quarter 2008 Financial Results and Business Progress 5Vermillion Announces First Quarter 2008 Financial Results and Business Progress 6Vermillion Announces First Quarter 2008 Financial Results and Business Progress 7Vermillion Announces First Quarter 2008 Financial Results and Business Progress 8Vermillion Announces First Quarter 2008 Financial Results and Business Progress 9
Mouse Anti-TGE Virus peplomer Monoclonal Antibody, Unconjugated, Clone 1Q17 from Abcam
Anti-Jak3 Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-14-3-3 tau Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Human ThPok Polyclonal Antibody, Unconjugated from Abcam
Biology Products: